Concepedia

Laura Sanftner

LS

Statistics

Publications

14

Citations

1.8K

H-Index

14

Active since

2004

Affiliations

Epigen Biosciences (United States)(Current)

University of California, San Francisco

Cornell University

Dana-Farber Cancer Institute

The Ohio State University

Laura Sanftner is an author at Epigen Biosciences (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

2004–2024

14

Publications

14

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

William D. Tap, Zev A. Wainberg, Stephen P. Anthony et al. · New England Journal of Medicine · 2015 · 571 citations

RAF inhibitors that evade paradoxical MAPK pathway activation

Chao Zhang, Wayne Spevak, Ying Zhang et al. · Nature · 2015 · 374 citations

, , +5

BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor

Hatice Gülçin Özer, Dalia El‐Gamal, Ben Powell et al. · Cancer Discovery · 2018 · 135 citations · Full text

The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain

Annemarie Ledeboer, Tongyao Liu, Jennifer A. Shumilla et al. · Neuron Glia Biology · 2006 · 120 citations · Full text

A Dose-Ranging Study of AAV-hAADC Therapy in Parkinsonian Monkeys

John Forsayeth, Jamie L. Eberling, Laura Sanftner et al. · Molecular Therapy · 2006 · 101 citations · Full text

1–5 of 14